CA1151067A - COMPOSITIONS PHARMACEUTIQUES ANTIARYTHMIQUES A ACTION PROLONGEE DONT LE PRINCIPE ACTIF EST 1'.alpha.-/2-/BIS (1-METHYL ETHYL) AMINO (ETHYL) .alpha.-PHENYL 2-PYRIDINE ACETAMIDEOU L'UN DE SES SELS - Google Patents

COMPOSITIONS PHARMACEUTIQUES ANTIARYTHMIQUES A ACTION PROLONGEE DONT LE PRINCIPE ACTIF EST 1'.alpha.-/2-/BIS (1-METHYL ETHYL) AMINO (ETHYL) .alpha.-PHENYL 2-PYRIDINE ACETAMIDEOU L'UN DE SES SELS

Info

Publication number
CA1151067A
CA1151067A CA000367273A CA367273A CA1151067A CA 1151067 A CA1151067 A CA 1151067A CA 000367273 A CA000367273 A CA 000367273A CA 367273 A CA367273 A CA 367273A CA 1151067 A CA1151067 A CA 1151067A
Authority
CA
Canada
Prior art keywords
alpha
ethyl
phenyl
amino
bis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000367273A
Other languages
English (en)
French (fr)
Inventor
John R. Bloor
Jacques Ser
Geoffrey Hayes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Application granted granted Critical
Publication of CA1151067A publication Critical patent/CA1151067A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
CA000367273A 1979-12-21 1980-12-19 COMPOSITIONS PHARMACEUTIQUES ANTIARYTHMIQUES A ACTION PROLONGEE DONT LE PRINCIPE ACTIF EST 1'.alpha.-/2-/BIS (1-METHYL ETHYL) AMINO (ETHYL) .alpha.-PHENYL 2-PYRIDINE ACETAMIDEOU L'UN DE SES SELS Expired CA1151067A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR79-31443 1979-12-21
FR7931443A FR2471784A1 (fr) 1979-12-21 1979-12-21 Medicaments antiarythmiques a action prolongee dont le principe actif est le a/2-/bis (1-methylethyl) amino/ethyl/-a-phenyl-2-pyridine acetamide ou ses sels, ainsi que le procede de preparation de ces nouveaux medicaments et compositions les renfermant

Publications (1)

Publication Number Publication Date
CA1151067A true CA1151067A (fr) 1983-08-02

Family

ID=9233075

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000367273A Expired CA1151067A (fr) 1979-12-21 1980-12-19 COMPOSITIONS PHARMACEUTIQUES ANTIARYTHMIQUES A ACTION PROLONGEE DONT LE PRINCIPE ACTIF EST 1'.alpha.-/2-/BIS (1-METHYL ETHYL) AMINO (ETHYL) .alpha.-PHENYL 2-PYRIDINE ACETAMIDEOU L'UN DE SES SELS

Country Status (13)

Country Link
JP (1) JPS56118016A (ko)
AU (1) AU543380B2 (ko)
BE (1) BE886774A (ko)
CA (1) CA1151067A (ko)
DE (1) DE3048154A1 (ko)
FR (1) FR2471784A1 (ko)
GB (1) GB2068226B (ko)
IT (1) IT1144024B (ko)
MA (1) MA19021A1 (ko)
NL (1) NL191171C (ko)
PT (1) PT72256B (ko)
SE (1) SE8007640L (ko)
ZA (1) ZA807807B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982004392A1 (en) * 1981-06-18 1982-12-23 Uclaf Roussel Method of preparing pharmaceutical compositions containing alpha-/2-/bis(1-methylethyl)amino/ethyl/alpha-phenyl 2-pyridine acetamide or one of its salts
US4789549A (en) * 1987-03-09 1988-12-06 Warner-Lambert Company Sustained release dosage forms
JPH08143450A (ja) * 1994-11-14 1996-06-04 Taiyo Yakuhin Kogyo Kk 徐放化製剤
ME02135B (me) * 2006-03-16 2015-04-30 Euro Celtique Sa Farmaceutski sferoidi

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3062720A (en) * 1959-05-20 1962-11-06 Philips Roxane Sustained release pharmaceutical tablet
FR2485M (fr) * 1961-05-17 1964-04-27 Searle & Co Nouveaux régulateurs cardiaques.
GB1021924A (en) * 1962-06-22 1966-03-09 Smith Kline French Lab Improvements in or relating to method of preparing sustained release tablets
BE708434A (ko) * 1966-12-22 1968-05-02

Also Published As

Publication number Publication date
GB2068226A (en) 1981-08-12
NL191171C (nl) 1995-03-01
DE3048154C2 (ko) 1992-03-19
DE3048154A1 (de) 1981-09-03
AU543380B2 (en) 1985-04-18
IT8050423A0 (it) 1980-12-19
NL8006938A (nl) 1981-07-16
IT1144024B (it) 1986-10-29
JPH0141606B2 (ko) 1989-09-06
NL191171B (nl) 1994-10-03
FR2471784A1 (fr) 1981-06-26
PT72256A (fr) 1981-01-01
JPS56118016A (en) 1981-09-16
ZA807807B (en) 1982-01-27
AU6560480A (en) 1981-06-25
MA19021A1 (fr) 1981-07-01
FR2471784B1 (ko) 1982-12-17
GB2068226B (en) 1984-03-21
SE8007640L (sv) 1981-06-22
PT72256B (fr) 1982-07-15
BE886774A (fr) 1981-06-19

Similar Documents

Publication Publication Date Title
JP3305315B2 (ja) 動物及び人間の疼痛及び／又は炎症の抑制時における薬剤ならびにその製造及びその使用
EP0133110B1 (fr) Nouvelle composition pharmaceutique à base d'acide valproique et son procédé de fabrication
JP4365107B2 (ja) 医薬組成物
FR2684876A1 (fr) Compositions pharmaceutiques stabilisees comprenant un compose inhibiteur de la hmg-coa reductase et procede pour leur preparation.
KR100742432B1 (ko) 암로디핀 캠실레이트 및 심바스타틴을 포함하는 복합제제,및 이의 제조방법
EP1773450B1 (fr) Combinaisons therapeutiques
EP1108424A1 (fr) Comprimé matriciel permettant la libération prolongée de trimétazidine après administration par voie orale
US3642986A (en) Aspirin-charcoal compositions
CA1151067A (fr) COMPOSITIONS PHARMACEUTIQUES ANTIARYTHMIQUES A ACTION PROLONGEE DONT LE PRINCIPE ACTIF EST 1'.alpha.-/2-/BIS (1-METHYL ETHYL) AMINO (ETHYL) .alpha.-PHENYL 2-PYRIDINE ACETAMIDEOU L'UN DE SES SELS
FR2676363A1 (fr) Antidote prophylactique contre les poisons organophosphoriques.
HU199293B (en) Process for production of tepically applicable medical compositions suitable for treatment of peptical ulcus by mammates
HU199775B (en) Process for production of formed by fatty acids salts of amin acids and medical compositions containing them
NZ534128A (en) Stable salts of O-acetylsalicylic acid containing basic amino acids II
FR2467596A1 (fr) Compositions pharmaceutiques de tiaramide ou de son sel et d'un agent reglant la dissolution, a longue duree d'action
CH651294A5 (fr) Acides amino-2-halogenobenzoyl-3-methylphenylacetiques et leurs esters et sels utiles comme medicaments anti-inflammatoires et analgesiques.
WO1982004392A1 (en) Method of preparing pharmaceutical compositions containing alpha-/2-/bis(1-methylethyl)amino/ethyl/alpha-phenyl 2-pyridine acetamide or one of its salts
CH664284A5 (en) Chloroquine medicaments without bitter taste - contain complex of chloroquine with copolymer of methacrylic] acid and methyl methacrylate]
RU2538674C2 (ru) Фармацевтическая композиция, обладающая пролонгированной противоаритмической активностью
FR2584604A1 (fr) Composition therapeutique constituant une nouvelle forme galenique orale pour ameliorer la cinetique de la biodisponibilite
Dąbrowska-Maś et al. New approaches to the synthesis of diclofenac choline
RU2155032C1 (ru) Способ получения лекарственной формы противовоспалительного симптоматического действия
JP2928261B2 (ja) 安定なポリプレニル系化合物含有組成物の製法
CA2022447A1 (fr) Forme galenique orale ameliorant la biodisponibilite
RU2277910C2 (ru) Средство "форинит-гель" для лечения и профилактики сердечно-сосудистых заболеваний
UA126659C2 (uk) Фармацевтичний склад, що містить бензокаїн з посиленою стабільністю

Legal Events

Date Code Title Description
MKEX Expiry